XYLOBODY
LIVE

Serial Number

99681085

Owner

MediciBIO Co., Ltd

Attorney

Sangwon Kim

Filing Date

Mar 3, 2026

Add to watchlist:

No watchlists yet
View on USPTO

XYLOBODY Trademark

Serial Number: 99681085

XYLOBODY is a trademark filed by MediciBIO Co., Ltd on March 3, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

MediciBIO Co., Ltd (2 trademarks)

A-2207, 184 Jungbu-daero, Giheung-gu, Yongin-si
Gyeonggi-do 17095 , KR

Entity Type: 22

Trademark Details

Filing Date

March 3, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention and treatment of cancer; Nutraceuticals for use as a dietary supplement; Medicinal healthcare preparations for the prevention and treatment of cancer; Pharmaceutical compositions in the nature of pain relief medication; Pharmaceuticals in the nature of antivirals; Nutraceutical preparations for therapeutic or medical purposes in particular for the prevention and treatment of cancer; Anti-oxidant food supplements; Chemical preparations for pharmaceutical purposes, in particular for the diagnosis of cancer; Drugs for medical purposes in particular for the prevention and treatment of cancer; Cachets for pharmaceutical purposes in the nature of capsules for the prevention and treatment of cancer

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 11, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 11, 2026 GNSL
SUSPENSION LETTER WRITTEN
Aug 11, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 17, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 17, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 17, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 3, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2026 NWOS
NEW APPLICATION ENTERED
Mar 3, 2026 NWAP